Literatura académica sobre el tema "HYPERTENSIVE DRUGS"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "HYPERTENSIVE DRUGS".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "HYPERTENSIVE DRUGS"
Wilson, J., M. A. Orchard, A. A. Spencer, J. A. Davies y C. R. M. Prentice. "Anti-Hypertensive Drugs Non-Specifically Reduce “Spontaneous” Activation of Blood Platelets". Thrombosis and Haemostasis 62, n.º 02 (1989): 776–80. http://dx.doi.org/10.1055/s-0038-1646901.
Texto completoO'Collins, Victoria E., Geoffrey A. Donnan, Malcolm R. Macleod y David W. Howells. "Hypertension and Experimental Stroke Therapies". Journal of Cerebral Blood Flow & Metabolism 33, n.º 8 (5 de junio de 2013): 1141–47. http://dx.doi.org/10.1038/jcbfm.2013.88.
Texto completoBhandary, Apeksha y Prasan R. Bhandari. "Drug usage pattern of anti-hypertensive drugs in elderly diabetic, hypertensive in-patients with or without impaired renal function in a tertiary care hospital". International Journal of Basic & Clinical Pharmacology 7, n.º 4 (23 de marzo de 2018): 696. http://dx.doi.org/10.18203/2319-2003.ijbcp20181172.
Texto completoRisna, Amalia, Jauhar Latifah, Linda Permata Sari, Ronalisa Ronalisa, Henny Maryani y Difa Intannia. "PROFIL PERESEPAN PENGGUNAAN ANTIHIPERTENSI PADA PASIEN RAWAT JALAN DI PUSKESMAS SUNGAI ULIN PERIODE OKTOBER 2020". Jurnal Insan Farmasi Indonesia 5, n.º 1 (29 de mayo de 2022): 8–15. http://dx.doi.org/10.36387/jifi.v5i1.913.
Texto completoCífková, Renata. "Antiplatelet and Lipid-lowering Drugs in Hypertension". European Cardiology Review 9, n.º 1 (2014): 16. http://dx.doi.org/10.15420/ecr.2014.9.1.16.
Texto completoRajak, Devraj, Deepali Sahu, Anushree Jain, Rubeena Khan, Basant Khare, Prateek Kumar Jain y Bhupendra Singh Thakur. "Review on Toxicity of Antihypertensive Drugs". Asian Journal of Dental and Health Sciences 2, n.º 4 (15 de diciembre de 2022): 64–68. http://dx.doi.org/10.22270/ajdhs.v2i4.28.
Texto completoUllah, Mohammad, Suman Kumar Saha, Md Toufiqur Rahman, Md Abdul Karim y Rashid Ahmed. "Nonadherence to Drugs among the Hypertensive Patients in Outpatient Department of a Secondary Hospital of Bangladesh". Cardiovascular Journal 11, n.º 2 (27 de febrero de 2019): 105–13. http://dx.doi.org/10.3329/cardio.v11i2.40409.
Texto completoRiungu, Dianah Kathambi y Patrick Mbataru. "Determinants of Accessibility of Hypertensive Drugs by Adult Patients Under Sustainable Development Goal Three in Nairobi City County, Kenya". International Journal of Current Aspects 5, n.º 4 (22 de noviembre de 2021): 108–19. http://dx.doi.org/10.35942/ijcab.v5i4.214.
Texto completoWalker, James Johnston. "Hypertensive Drugs in Pregnancy". Clinics in Perinatology 18, n.º 4 (diciembre de 1991): 845–73. http://dx.doi.org/10.1016/s0095-5108(18)30499-8.
Texto completoBrubaker, R. F. "Ocular hypertensive drugs—Overview". Experimental Eye Research 55 (septiembre de 1992): 185. http://dx.doi.org/10.1016/0014-4835(92)90845-j.
Texto completoTesis sobre el tema "HYPERTENSIVE DRUGS"
Nievelstein, Hubert Nicolas Maria Willem. "Hemodynamic effects of antihypertensive drugs in conscious spontaneously hypertensive rats". Maastricht : Maastricht : Rijksuniversiteit Limburg ; University Library, Maastricht University [Host], 1987. http://arno.unimaas.nl/show.cgi?fid=5367.
Texto completoBeaubien, Eliot R. "Non-steroidal anti-inflammatory drugs and the risk of end stage renal disease in hypertensive individuals". Thesis, McGill University, 2004. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=81593.
Texto completoStudy design. We conducted a nested case-control study within a cohort of 77,887 hypertensive adult subjects within the province of Saskatchewan, Canada.
Outcome. The primary outcome was ESRD, defined by chronic dialysis or renal transplantation.
Exposure. NSAID exposure was determined using prescription records, for various time windows up to 10 years preceding the onset of end stage renal disease.
Statistical analysis. Rate ratios (RR) were estimated with 95% confidence intervals using conditional logistic regression, adjusting for potential confounding variables and stratified for effect modifiers.
Results. We identified 397 cases and 7,399 controls. In subjects followed for at least 10 years continuous NSAID use was observed in 20.8% of cases and 17.9% of controls (RR = 1.18, 95% CI 0.68--2.05). Additionally, neither early (RR = 1.10, 95% CI 0.50--2.41) nor late (RR = 0.81, 95% CI 0.32--2.04) NSAID exposure was associated with ESRD during this time period. Evaluation of other time windows (0--2 years, 2--5 years and 5--10 years) and NSAID dosing provided similar results. Results were not modified by loop diuretic and angiotensin converting enzyme inhibitor use.
Conclusion. Up to 10 years of non-steroidal anti-inflammatory drug use does not appear to influence the development of end stage renal disease. These results however may be influenced by unmeasured co-morbidities and confounding by "contra-indication".
Komulainen, S. (Silja). "Effect of antihypertensive drugs on blood pressure during exposure to cold:experimental study in normotensive and hypertensive subjects". Doctoral thesis, University of Oulu, 2007. http://urn.fi/urn:isbn:9789514286131.
Texto completoTiivistelmä Tutkimuksen tarkoituksena oli selvittää eri mekanismeilla vaikuttavien verenpainelääkkeiden vaikutusta verenpainevasteisiin ja sydämen lyöntitiheyteen kylmässä sekä verrata erilaisten kylmäaltistusten vaikutusta verenpaineeseen ja sydämen lyöntitiheyteen. Tutkitut lääkkeet edustivat seuraavia verenpainelääkeryhmiä: metoprololi beetasalpaajia, karvediloli yhdistettyjä alfa- ja beetasalpaajia, lisinopriili ACE-estäjiä, eprosartaani angiotensiini II antagonisteja, amlodipiini kalsiumestäjiä ja hydroklooritiatsidi diureetteja. Tärkeimmät mitatut vasteet olivat systolisen ja diastolisen verenpaineen ja sydämen lyöntitiheyden tasot ja muutokset ennen kylmäaltistusta, kylmäaltistuksen aikana ja sen jälkeen. Lisäksi mitattiin lämpötilavasteita ja tuntemuksia. Normo- ja hypertensiiviset koehenkilöt altistettiin joko –15°C:seen 15 minuutin ajaksi (talvivaatetuksessa), 5°C:seen 45 minuutin ajaksi (minimaalisella vaatetuksella) tai tehtiin ns. käden kylmävesitesti (CPT). Testisarjoissa (–15°C) metoprololi, karvediloli, lisinopriili, eprosartaani ja hydroklooritiatsidi tai plasebo annettiin viikon ajan kaksoissokko- ja vaihtovuoromenetelmällä. Yhdessä testisarjassa (5°C ja CPT) koehenkilöt ottivat amlodipiinia 3 päivän ajan tai olivat ilman lääkettä ennen testikertoja vaihtovuoroisessa järjestyksessä. Kaikki kylmäaltistustyypit nostivat merkittävästi sekä systolista että diastolista verenpainetta. Systolisen ja diastolisen verenpaineen nousu oli korkeampi koko kehon kylmäaltistuksissa (5°C tai –15°C) (19–35/20–24 mmHg) kuin ns. kylmävesitestissä (13/16 mmHg). Metoprololi, karvediloli, lisinopriili, eprosartaani ja amlodipiini laskivat verenpaineen tasoja koko kehon kylmäaltistuksessa verrattuna plaseboon. Yksikään verenpainelääkkeistä ei vaikuttanut merkittävästi kylmän aiheuttamaan verenpaineen nousuun verrattuna tutkimuskertaan ilman lääkettä tai plaseboon. Sydämen lyöntitiheys nousi ns. kylmävesitestin aikana, mutta laski koko kehon kylmäaltistuksissa (5°C ja –15°C). Metoprololi ja karvediloli laskivat sydämen lyöntiheyttä kylmäaltistuksessa (–15°C) verrattuna plaseboon. Tämä tutkimus kuvaa ensimmäistä kertaa, kuinka verenpainelääkkeet vaikuttavat verenpainetasoihin ja -vasteisiin kylmäaltistuksessa, joka simuloi tyypillisiä ulko-olosuhteita talvella. Vaikka lääkkeet eivät estäneet kylmän aiheuttamaa verenpaineen nousua, ne laskivat verenpaineen tasoa, jolloin verenpaine pysyi kylmässäkin lähempänä suositusrajoja
Filho, Gilberto Senechal de Goffredo. "Incapacidade temporária para atividades habituais: relação com a pressão arterial e o uso de terapia farmacológica antihipertensiva no Estudo Pró-Saúde". Universidade do Estado do Rio de Janeiro, 2008. http://www.bdtd.uerj.br/tde_busca/arquivo.php?codArquivo=5021.
Texto completoArterial hypertension (AH) plays a determinant role in the occurrence of severe clinical events; however, there are controversies about its impact on daily life. The temporary disability for daily activities, which is defined as a temporary restriction in an individuals usual level of functioning, is a health indicator proposed by the World Health Organization for utilization in population studies. To investigate the association between arterial hypertension and temporary disability for daily activities, we proposed the following specific objectives: A) To investigate whether elevated blood pressure (BP) determine the frequency or accumulated period of temporary disability for daily activities; 2) To investigate whether the use of anti-hypertensive drugs are associated with changes in the frequency or accumulated period of temporary disability for daily activities. We have a cross-sectional study with data obtained from 2953 participants who answered a self administered questionnaire in the Pro-Saude Study, a cohort of university employees in Rio de Janeiro state. The exposure was evaluated using the measured value of BP and the report of the use of anti-hypertensive drugs. We conducted the analysis classifying the participants in 4 groups, combining the information about measured BP (< or 140/90 mmHg) and the report of the use of anti-hypertensive drugs or not. The outcome was evaluated with a composite variable with information about the report and period of disability. Multivariate analyses were conducted using multinomial logistic regression. The results are 690 (23.4 %) were classified as hypertensives, and 704 (23.8 %) reported temporary disability. The use of antihypertensive drugs, among the participants with BP < 140/90 mmHg, was directly associated with the prevalence of temporary disability for daily activities for a longer period (OR=2.25, CI 95 %: 1.31 - 3.87). The presence of BP 140/90 mmHg showed an inverse relationship with the chance of temporary disability for a short period among the participants that did not use ntihypertensive drugs, not reaching statistical significance (OR=0.64; CI 95 %: 0.40 - 1.03). We found a direct association between the use of anti-hypertensive drugs and temporary disability for daily activities for a long period, which may be related to adverse effects of the drugs; the results also suggest an inverse relationship between BP values and the prevalence of temporary disability for a short period, which did not reach statistical significance, and can be related to a phenomenon known as AH-asociated hypalgesia.
Forino, Andrew Stephen. "Determining Effects of the PAF-R and Anti-Hypertensive Drugs Mediated Microvesicle Particle Release in Modulating Anti-Tumor Response of Lung Cancer". Wright State University / OhioLINK, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=wright1590691151424173.
Texto completoMerlo, Juan. "Pharmacoepidemiologic studies on cardiovascular drugs with special reference to the effectiveness and safety of blood pressure lowering drugs /". Lund : Dept. of Community Medicine, Lund University, and the NEPI Foundation, 1998. http://books.google.com/books?id=c_BsAAAAMAAJ.
Texto completoMoore, Suzanne P. "Adherence to randomised drug regimens of patients enrolled in the Second Australian National Blood Pressure Study : a description of the patterns of adherence and of factors influencing non-adherence /". [St. Lucia, Qld.], 2001. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe16251.pdf.
Texto completoYates, John. "Haemodynamic effects of vasoactive drugs in experimental portal hypertension". Thesis, Liverpool John Moores University, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.337787.
Texto completoYu, Zhen. "Altered drug responses in diabetic and hypertensive-diabetic cardiomyopathy". Thesis, University of British Columbia, 1990. http://hdl.handle.net/2429/29406.
Texto completoPharmaceutical Sciences, Faculty of
Graduate
Greer, I. A. "The effect of anti-hypertensive agents on platelets, prostacylin and thromboxane and observations on prostacyclin and thromboxane in normal and hypertensive pregnancy". Thesis, University of Glasgow, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.380334.
Texto completoLibros sobre el tema "HYPERTENSIVE DRUGS"
Heart attacks, hypertension, and heart drugs. Emmaus, Pa: Rodale Press, 1987.
Buscar texto completoM, Drayer Jan I., Lowenthal David T y Weber Michael A, eds. Drug therapy in hypertension. New York: Dekker, 1987.
Buscar texto completoSwitzerland) International Symposium Clonidine in Hypertension (1984 Geneva. Low dose oral and transdermal therapy of hypertension: International Symposium Clonidine in Hypertension, Geneva, 14th-16th June, 1984. Darmstadt: Steinkopff, 1985.
Buscar texto completo1947-, Martin John E. y Dubbert Patricia M, eds. Non-drug treatments for essential hypertension. New York: Pergamon Press, 1988.
Buscar texto completoH, Messerli Franz y Opie Lionel H, eds. Combination drug therapy for hypertension. New York: Author's Pub. House, 1997.
Buscar texto completoMann, Samuel J. Hypertension and you: Old drugs, new drugs, and the right drugs for your high blood pressure. Lanham: Rowman & Littlefield Publishers, 2012.
Buscar texto completovan, Zwieten P. A. y Greenlee William J, eds. Antihypertensive drugs. Amsterdam, the Netherlands: Harwood Academic Publishers, 1997.
Buscar texto completoH, Messerli Franz, ed. The Heart and hypertension. New York, N.Y: Yorke Medical Books, 1987.
Buscar texto completoBönner, Gerd. Prostacyclin and hypertension. Berlin: Springer-Verlag, 1990.
Buscar texto completoLower blood pressure without drugs: Curing your hypertension naturally. 2a ed. Garden City Park, NY: Square One Publishers, 2012.
Buscar texto completoCapítulos de libros sobre el tema "HYPERTENSIVE DRUGS"
Iturrioz, Xavier, Annabelle Reaux, Le Goazigo y Catherine Llorens-Cortes. "Aminopeptidase Inhibitors as Anti-Hypertensive Drugs". En Aminopeptidases in Biology and Disease, 229–50. Boston, MA: Springer US, 2004. http://dx.doi.org/10.1007/978-1-4419-8869-0_11.
Texto completoKuriyama, Yoshihiro, Tohru Sawada y Teruo Omae. "Antihypertensive Drugs and Cerebral Circulation". En How Should Elderly Hypertensive Patients Be Treated?, 69–83. Tokyo: Springer Japan, 1989. http://dx.doi.org/10.1007/978-4-431-68340-7_5.
Texto completoCockcroft, John R. y David J. Webb. "Phase I Trials on Anti-hypertensive Drugs". En Early Phase Drug Evaluation in Man, 302–12. London: Macmillan Education UK, 1990. http://dx.doi.org/10.1007/978-1-349-10705-6_24.
Texto completoVoicu, Victor y Maria Dorobantu. "New Drugs for the Hypertensive Failing Heart". En Updates in Hypertension and Cardiovascular Protection, 313–34. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-93320-7_20.
Texto completoNakamaru, Mitsuaki, Toshio Ogihara, Hiroshi Mikami, Fuminori Masugi, Jitsuo Higaki, Atsuhiro Otsuka, Takeshi Hata y Yuichi Kumahara. "Complications and the Choice of Antihypertensive Drugs in the Elderly". En How Should Elderly Hypertensive Patients Be Treated?, 213–18. Tokyo: Springer Japan, 1989. http://dx.doi.org/10.1007/978-4-431-68340-7_21.
Texto completoSarros, G., H. Nastou, A. Nastos, V. Sarrou, N. Fotopoulos y J. Anastassopoulou. "Molecular Design and FT-IR Spectra of Hypertensive Drugs". En Spectroscopy of Biological Molecules, 565–66. Dordrecht: Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0371-8_261.
Texto completoKirpizidis, H. G. "Quality of Life, Drugs and Diet in Hypertensive Patients". En Handbook of Disease Burdens and Quality of Life Measures, 2965–86. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-0-387-78665-0_173.
Texto completoAgrawal, S. S. "Development of Transdermal and Transbuccal Drug Delivery Systems for Cardioactive Drugs with Special Reference to Anti- Hypertensive Agents". En Atherosclerosis, Hypertension and Diabetes, 229–46. Boston, MA: Springer US, 2003. http://dx.doi.org/10.1007/978-1-4419-9232-1_19.
Texto completoEscher, Emanuel. "Angiotensin II Antagonists with Prolonged Duration of Action Possible Anti-Hypertensive Drugs". En Molecular Biology of Brain and Endocrine Peptidergic Systems, 29–45. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-8801-2_3.
Texto completoBernstein, Donald P. "How Should You Manage Anti-Hypertensive Drugs in Morbidly Obese Surgical Patients?" En Controversies in the Anesthetic Management of the Obese Surgical Patient, 91–101. Milano: Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2634-6_8.
Texto completoActas de conferencias sobre el tema "HYPERTENSIVE DRUGS"
Wilson, J., M. A. Orchard, A. A. Spencer, J. A. Davies y C. R. M. Prentice. "TREATMENT OF RAISED BLOOD PRESSURE WITH NISOLDIPINE REDUCES "SPONTANEOUS" PLATELET AGGREGATION IN WHOLE BLOOD". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644260.
Texto completoMartins, A. V. V., J. G. A. L. Junior, L. A. Bortolotto, G. Lorenzi-Filho y L. F. Drager. "Insomnia is Common in Patients with Hypertension and Associated with Higher Need of Anti-hypertensive Drugs". En XIX Congresso Brasileiro do Sono. Thieme Revinter Publicações Ltda., 2023. http://dx.doi.org/10.1055/s-0043-1770250.
Texto completoSuryantara, A. A., I. Suyasa, Ni Kamaryati y Ida Diyu. "Determinant Factors Affecting Adherence of Hypertensive Patients to Taking Antihypertensive Drugs". En The Bali Biennial International Conference on Health Sciences. SCITEPRESS - Science and Technology Publications, 2022. http://dx.doi.org/10.5220/0011940700003576.
Texto completoYalcin, Huseyin C., Mohamed A. Elrayess, Hadeel T. Al-Jighefee, Mahmoud Khatib A. A. Al-Ruweidi, Shamma Almuraikhy y Hadi M. Yassine. "Soluble ACE2 and Angiotensin II levels Modulated in Hypertensive COVID-19 Patients treated with different Antihypertension Drugs". En Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0085.
Texto completoPrihayati, Apriliya y Pujiyanto Pujiyanto. "Drug Utilization Pattern and Cost Estimates of Anti-Hypertensive Drugs in Pharmacies under the National Health Insurance Program". En The 6th International Conference on Public Health 2019. Masters Program in Public Health, Graduate School, Universitas Sebelas Maret, 2019. http://dx.doi.org/10.26911/the6thicph-fp.04.06.
Texto completoPrihayati, Apriliya y Pujiyanto Pujiyanto. "Drug Utilization Pattern and Cost Estimates of Anti-Hypertensive Drugs in Pharmacies Under the National Health Insurance Program". En The 6th International Conference on Public Health 2019. Masters Program in Public Health, Graduate School, Universitas Sebelas Maret, 2019. http://dx.doi.org/10.26911/the6thicph.04.60.
Texto completoRajendran, Rasvini y Zaitul Marlizawati Zainuddin. "The Determining Factors in Prescribing Anti-Hypertensive Drugs to First-Ever Ischemic Stroke Patients". En 2016 International Conference on Industrial Engineering, Management Science and Application (ICIMSA). IEEE, 2016. http://dx.doi.org/10.1109/icimsa.2016.7504041.
Texto completoDaudt, Pedro Eugênio Deboni, Alexandre Grunfeld Starling Jardim y Felipe Ibiapina dos Reis. "Arterial hypertension and cerebrovascular accidents. epidemiological profile of patients attended between 2013 and 2019 in Joinville, Santa Catarina, Brazil." En XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.344.
Texto completoDaudt, Pedro Eugênio Deboni, Alexandre Grunfeld Starling Jardim y Felipe Ibiapina dos Reis. "Arterial hypertension and cerebrovascular accidents. epidemiological profile of patients attended between 2013 and 2019 in Joinville, Santa Catarina, Brazil". En XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.475.
Texto completoVaibavi, S. R., Rahul Vaippully, Basudev Roy y Saumendra K. Bajpai. "Anti-hypertensive Calcium-Blocking Drugs Induce a Change in Viscoelasticity of Mcf-7 Cancer Cells". En ICBET 2020: 2020 10th International Conference on Biomedical Engineering and Technology. New York, NY, USA: ACM, 2020. http://dx.doi.org/10.1145/3397391.3397420.
Texto completoInformes sobre el tema "HYPERTENSIVE DRUGS"
Fillipin, Federico, Pamela Seron y Ruvistay Gutierrez-Arias. Effectiveness of antihypertensive drugs to prevent cognitive decline, mild cognitive impairment, and dementia. An overview of systematic reviews. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, diciembre de 2022. http://dx.doi.org/10.37766/inplasy2022.12.0057.
Texto completoXin, Yuning, Hongyu Li, Gungyu Cheng, Junfeng Cui, Yinghui Liu, Aidong Liu, Xiaolin Xu, Pengfei Li y Huize Han. Evaluation of the Effectiveness and Safety of Acupuncture in the Treatment of Cervicogenic Hypertension A Protocol for Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, diciembre de 2022. http://dx.doi.org/10.37766/inplasy2022.12.0036.
Texto completoLi, YueXin, YangXiao Chen, Lin Fu, YangHang Chen, Ni Ren, Qian Jiang, Ran Ma et al. A Bayesian Network Meta-analysis on the Efficacy and Safety of Novel Targeted Drugs for Type Ⅰ Pulmonary Hypertension. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, diciembre de 2020. http://dx.doi.org/10.37766/inplasy2020.12.0023.
Texto completoZhao, Jing, Yuanyuan Zeng, Jieqiong Weng, Jingfang Zhang, Tingting Yao, Mengfei Yuan y Xiaoxu Shen. Evening dosing versus morning regimen drug therapy for hypertension: a meta-analysis of randomized controlled trial. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, agosto de 2021. http://dx.doi.org/10.37766/inplasy2021.8.0005.
Texto completoTreadwell, Jonathan R., James T. Reston, Benjamin Rouse, Joann Fontanarosa, Neha Patel y Nikhil K. Mull. Automated-Entry Patient-Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes. Agency for Healthcare Research and Quality (AHRQ), marzo de 2021. http://dx.doi.org/10.23970/ahrqepctb38.
Texto completoLifestyle changes may be more important than drugs for mild hypertension. National Institute for Health Research, enero de 2019. http://dx.doi.org/10.3310/signal-000713.
Texto completoIntroducing magnesium sulphate for the management of pregnancy induced hypertension. Population Council, 2005. http://dx.doi.org/10.31899/rh16.1012.
Texto completo